The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Seroquel

Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R) - NASDAQ

TORONTO, July 31, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc.(Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted ...

AstraZeneca sales hit hard by generic competition - Reuters

LONDON (Reuters) - AstraZeneca's sales tumbled 21 percent in the second quarter, punished by generic competition to its best-selling antipsychotic medicine Seroquel and pressure on health spending in Europe. Continued supply chain disruptions ...

Intellipharmaceutics and AstraZeneca settle patent litigation for generic Seroquel XR in the District Court for the Southern District of New York - MENAFN

Aug 01, 2012 (M2 EQUITYBITES via COMTEX) -- Pharmaceutical company Intellipharmaceutics International Inc (nasdaqcm:IPCI) said on Tuesday that it has settled all outstanding commercial patent litigation concerning its abbreviated new drug application (ANDA ...

AstraZeneca sales tumble 18% in second quarter - The Guardian

AstraZeneca has been hit hard by competition to its antipsychotic drug Seroquel, until now one of its bestsellers, from generic drugs as well as lower health spending in Europe. Quarterly sales tumbled 18% in the second quarter, also dragged ...

AstraZeneca Profit Hit By Generics, Yet Tops View; Backs Forecast - RTT News

(RTTNews) - Anglo-Swedish drug maker AstraZeneca Plc (AZN:Quote, AZN.L) Thursday said its second-quarter profit was severely affected by loss of exclusivity on several key brands, including neuroscience drug Seroquel IR and key cardiovascular drug Crestor ...

Generics drag AZ sales down by $1.35B - FiercePharma

AstraZeneca's second-quarter results continue the generics-are-woe trend in Big Pharma. This time, it's the antipsychotic drug Seroquel doing most of the damage. It fell over the patent cliff at the end of March, as the first quarter drew to a ...

STOCKS NEWS EUROPE-AstraZeneca weak as Q2 revenues miss - CNBC

Shares in AstraZeneca shed 1.5 percent, weighing on an otherwise positive drugs sector, as the firm posts a big drop in second quarter sales, punished by generic competition to its best-selling antipsychotic medicine Seroquel and pressure on health ...

AstraZeneca profits dive on patent expiries - YAHOO!

The company faces crucial patent expiries between 2012 and 2015 on drugs such as schizophrenia treatment Seroquel and heartburn and ulcer drug Nexium. It will also suffer the loss of patent protection in the United States for its best-selling anti ...
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Marc Faber blog
 
Blogspot logo    Latest Posts from Henrique Simoes blog
 
  Latest Posts from Mad Money 
Cramer?s Exec Cut: The benefits and dangers of advancing technology
Cramer Remix: The 2 distinct places investors should keep their cash
Cramer makes the bull case for including bonds in your portfolio
Cramer shares the best way to get your child excited about investing
Cramer: How compounding can help you double your money in 7 years
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 437
 
Blogspot logo    Latest Posts from Random Roger
Serious Retirement Downsizing
Planning Advice From True Experts
James Altucher is Right, Retirees Shouldn?t Own A Home
?You?ll Be Stone Dead In A Moment?
Rock You Like A Hurricane
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.